Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1988 1
1997 1
1998 1
1999 2
2000 3
2002 2
2003 2
2004 6
2005 1
2006 4
2007 3
2008 3
2009 3
2010 2
2011 5
2012 6
2013 4
2014 6
2015 10
2016 4
2017 8
2018 15
2019 17
2020 15
2021 14
2022 12
2023 12
2024 22
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study.
Alvarez GV, Kang BY, Richmond AM, Hoss E, Sulewski R, Minkis K, Rozenberg SS, Antonovich D, Boucher A, Bernstein EF, Bertucci V, Chapas AM, Cohen JL, Council ML, Dover JS, Geronemus R, Given KML, Goldbach HS, Goldman MP, Hooper D, Kaufman J, Munavalli G, Pacheco TR, Rossi AM, Wilson S, Alam M. Alvarez GV, et al. Among authors: pacheco tr. J Am Acad Dermatol. 2025 Apr 14:S0190-9622(25)00612-7. doi: 10.1016/j.jaad.2025.04.021. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 40233838
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Scirica BM, et al. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Free article. Clinical Trial.
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. Kim EJ, et al. Among authors: pacheco t. JAMA Dermatol. 2022 Sep 1;158(9):1031-1039. doi: 10.1001/jamadermatol.2022.2749. JAMA Dermatol. 2022. PMID: 35857290 Free PMC article. Clinical Trial.
Immunotherapy in lung cancer brain metastases.
Paisana E, Cascão R, Alvoeiro M, Félix F, Martins G, Guerreiro C, Roque R, Cruz R, Pacheco TR, Amado AC, Ferro F, Lopes Machado A, Vilariça AS, Hasmucrai D, Alves P, Faria CC. Paisana E, et al. Among authors: pacheco tr. NPJ Precis Oncol. 2025 May 6;9(1):130. doi: 10.1038/s41698-025-00901-0. NPJ Precis Oncol. 2025. PMID: 40328894 Free PMC article. Review.
Scanning the aged to minimize missed injury: An Eastern Association for the Surgery of Trauma multicenter study.
Ho VP, Kishawi SK, Hill H, O'Brien J, Ratnasekera A, Seng SS, Ton TH, Butts CA, Muller A, Diaz BF Jr, Baltazar GA, Petrone P, Pacheco TBS, Morrissey S, Chung T, Biller J, Jacobson LE, Williams JM, Nebughr CS, Udekwu PO, Tann K, Piehl C, Veatch JM, Capasso TJ, Kuncir EJ, Kodadek LM, Miller SM, Altan D, Mentzer C, Damiano N, Burke R, Earley A, Doris S, Villa E, Wilkinson MC, Dixon JK, Wu E, Moncrief ML, Palmer B, Herzing K, Egodage T, Williams J, Haan J, Lightwine K, Colling KP, Harry ML, Nahmias J, Tay-Lasso E, Cuschieri J, Hinojosa CJ, Claridge JA. Ho VP, et al. Among authors: pacheco tbs. J Trauma Acute Care Surg. 2025 Jan 1;98(1):101-110. doi: 10.1097/TA.0000000000004390. Epub 2024 Dec 14. J Trauma Acute Care Surg. 2025. PMID: 38797882
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Ridker PM, et al. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304242 Free article. Clinical Trial.
Exploring new pathways in endocrine-resistant breast cancer.
de Pinho IS, Abreu C, Gomes I, Casimiro S, Pacheco TR, de Sousa RT, Costa L. de Pinho IS, et al. Among authors: pacheco tr. Explor Target Antitumor Ther. 2022;3(3):337-361. doi: 10.37349/etat.2022.00086. Epub 2022 Jun 20. Explor Target Antitumor Ther. 2022. PMID: 36045911 Free PMC article. Review.
183 results